BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2576797)

  • 1. Measurement of the relative binding affinity of zearalenone, alpha-zearalenol and beta-zearalenol for uterine and oviduct estrogen receptors in swine, rats and chickens: an indicator of estrogenic potencies.
    Fitzpatrick DW; Picken CA; Murphy LC; Buhr MM
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1989; 94(2):691-4. PubMed ID: 2576797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. alpha-Zearalenol, a major hepatic metabolite in rats of zearalenone, an estrogenic mycotoxin of Fusarium species.
    Ueno Y; Tashiro F
    J Biochem; 1981 Feb; 89(2):563-71. PubMed ID: 6453865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transformation of zearalenone and zearalenol by rat erythrocytes.
    Chang WM; Lin JK
    Food Chem Toxicol; 1984 Nov; 22(11):887-91. PubMed ID: 6238883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma and urinary levels of zearalenone and alpha-zearalenol in a prepubertal gilt fed zearalenone.
    Olsen M; Malmlöf K; Pettersson H; Sandholm K; Kiessling KH
    Acta Pharmacol Toxicol (Copenh); 1985 Mar; 56(3):239-43. PubMed ID: 3160216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zearalenone metabolism and excretion in the rat: effect of different doses.
    Fitzpatrick DW; Arbuckle LD; Hassen AM
    J Environ Sci Health B; 1988 Aug; 23(4):343-54. PubMed ID: 2973490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmission of zearalenone and zearalenol into porcine milk.
    Palyusik M; Harrach B; Mirocha CJ; Pathre SV
    Acta Vet Acad Sci Hung; 1980; 28(2):217-22. PubMed ID: 6453516
    [No Abstract]   [Full Text] [Related]  

  • 7. Fish model for assessing the in vivo estrogenic potency of the mycotoxin zearalenone and its metabolites.
    Arukwe A; Grotmol T; Haugen TB; Knudsen FR; Goksøyr A
    Sci Total Environ; 1999 Sep; 236(1-3):153-61. PubMed ID: 10535150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioconversion of alpha-[14C]zearalenol and beta-[14C]zearalenol into [14C]zearalenone by Fusarium roseum 'Gibbosum'.
    Richardson KE; Hagler WM; Hamilton PB
    Appl Environ Microbiol; 1984 Jun; 47(6):1206-9. PubMed ID: 6742839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Species differences in zearalenone-reducing activity in subcellular fractions of liver from female domestic animals.
    Olsen M; Kiessling KH
    Acta Pharmacol Toxicol (Copenh); 1983 Apr; 52(4):287-91. PubMed ID: 6223507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biotransformation of zearalenone to zearalenol by Candida tropicalis.
    Palyusik M; Hagler WM; Horváth L; Mirocha CJ
    Acta Vet Acad Sci Hung; 1980; 28(2):159-66. PubMed ID: 6453514
    [No Abstract]   [Full Text] [Related]  

  • 11. Hydroxysteroid dehydrogenases in bovine and porcine granulosa cells convert zearalenone into its hydroxylated metabolites alpha-zearalenol and beta-zearalenol.
    Malekinejad H; Colenbrander B; Fink-Gremmels J
    Vet Res Commun; 2006 May; 30(4):445-53. PubMed ID: 16502112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogenic activity of zearalenone, α-zearalenol and β-zearalenol assessed using the E-screen assay in MCF-7 cells.
    Tatay E; Espín S; García-Fernández AJ; Ruiz MJ
    Toxicol Mech Methods; 2018 May; 28(4):239-242. PubMed ID: 29057713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro metabolism of the anabolic drug zeranol.
    Ingerowski GH; Stan HJ
    J Environ Pathol Toxicol; 1979; 2(4):1173-82. PubMed ID: 448258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary influences on excretory pathways and tissue residues of zearalenone and zearalenols in the rat.
    Smith TK
    Can J Physiol Pharmacol; 1982 Dec; 60(12):1444-9. PubMed ID: 6299487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of high concentrations of dietary zearalenone by young male turkey poults.
    Olsen M; Mirocha CJ; Abbas HK; Johansson B
    Poult Sci; 1986 Oct; 65(10):1905-10. PubMed ID: 2948167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding properties of zearalenone mycotoxins to hepatic estrogen receptors.
    Powell-Jones W; Raeford S; Lucier GW
    Mol Pharmacol; 1981 Jul; 20(1):35-42. PubMed ID: 6457245
    [No Abstract]   [Full Text] [Related]  

  • 17. Estrogenic activity of zearalenone and zearalanol in the neonatal rat uterus.
    Sheehan DM; Branham WS; Medlock KL; Shanmugasundaram ER
    Teratology; 1984 Jun; 29(3):383-92. PubMed ID: 6235618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogenic potencies of resorcylic acid lactones and 17 beta-estradiol in female rats.
    Everett DJ; Perry CJ; Scott KA; Martin BW; Terry MK
    J Toxicol Environ Health; 1987; 20(4):435-43. PubMed ID: 2951527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into In Vivo Absolute Oral Bioavailability, Biotransformation, and Toxicokinetics of Zearalenone, α-Zearalenol, β-Zearalenol, Zearalenone-14-glucoside, and Zearalenone-14-sulfate in Pigs.
    Catteuw A; Broekaert N; De Baere S; Lauwers M; Gasthuys E; Huybrechts B; Callebaut A; Ivanova L; Uhlig S; De Boevre M; De Saeger S; Gehring R; Devreese M; Croubels S
    J Agric Food Chem; 2019 Mar; 67(12):3448-3458. PubMed ID: 30807145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of zearalenone and its reduced metabolites α-zearalenol and β-zearalenol with serum albumins: species differences, binding sites, and thermodynamics.
    Faisal Z; Lemli B; Szerencsés D; Kunsági-Máté S; Bálint M; Hetényi C; Kuzma M; Mayer M; Poór M
    Mycotoxin Res; 2018 Nov; 34(4):269-278. PubMed ID: 30014206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.